Cutler Group LP Alx Oncology Holdings Inc Transaction History
Cutler Group LP
- $307 Million
- Q1 2024
A detailed history of Cutler Group LP transactions in Alx Oncology Holdings Inc stock. As of the latest transaction made, Cutler Group LP holds 3,000 shares of ALXO stock, worth $3,300. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,000Holding current value
$3,300% of portfolio
0.0%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding ALXO
# of Institutions
96Shares Held
39.5MCall Options Held
213KPut Options Held
44.8K-
Ven Bio Partners LLC San Francisco, CA9.7MShares$10.7 Million13.33% of portfolio
-
Redmile Group, LLC San Francisco, CA3.69MShares$4.06 Million0.48% of portfolio
-
Tang Capital Management LLC San Diego, CA3.3MShares$3.63 Million0.41% of portfolio
-
Black Rock Inc. New York, NY2.69MShares$2.96 Million0.0% of portfolio
-
Morgan Stanley New York, NY2.5MShares$2.75 Million0.0% of portfolio
About ALX ONCOLOGY HOLDINGS INC
- Ticker ALXO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 40,747,100
- Market Cap $44.8M
- Description
- ALX Oncology Holdings Inc., a clinical-stage immuno-oncology company, focuses on developing therapies for patients fighting cancer. Its lead product candidate is ALX148, a CD47 blocking therapeutic that is in Phase 1b/2 clinical trial used for the treatment of myelodysplastic syndromes; and for the treatment of acute myeloid leukemia and non-Hod...